FCRL6 and neoplasm: Interestingly, high FCRL6 expression has been detected on NK cells within HLA-II+ solid tumors, and blocking of FCRL6 increased the functional response of NK cells as well as T cells toward HLA-DR+ tumor cells (Johnson et al., 2018).